// App-Quantinova.ai

PB0432 : The ADAMTS-13 / von Willebrand factor (VWF) ratio as a prognostic biomarker for the development of portal vein thrombosis (PVT) in patients with compensated cirrhosis.

Researchers

Presenter

  • R. De Cristofaro

Principal Investigators

  • S. Lancellotti

  • M. Sacco

  • M. Tardugno

  • A. De Magistris

  • M. Basso

  • M. Pompili

  • A. Grieco

Medical Centers

  • Catholic University of Sacred Heart, Translational Medicine and Surgery Department, Rome, Lazio, Italy

  • Fondazione Policlinico Universitario A. Gemelli, IRCCS, Center for Hemorrhagic and Thrombotic Diseases and Haemophilia Center, Rome, Rome, Lazio, Italy

  • Fondazione Policlinico Universitario A. Gemelli, IRCCS, Department of Digestive, Endocrine and Metabolic System, Institute of Internal Medicine and Geriatrics, Rome., Rome, Lazio, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Gastroenterology (GU)

Disease

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • D-dimer

  • von Willebrand factor

  • Lactate

  • Activated partial thromboplastin time

Drug/Treatment

  • Fibrinogen (IV)

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT03322696

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved